Vulvar cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Line 22: | Line 22: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''Asian''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''American Indian'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Non-Hispanic''' | |style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Non-Hispanic''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |6.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |15.3% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |22.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |14.9% | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |6.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |15.3% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |22.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |14.9% |
Revision as of 19:28, 21 September 2015
Vulvar cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vulvar cancer epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics |
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
In 2012, the incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States.
Incidence
The incidence of vulvar cancer was 2.4 per 100,000 women per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.[1]
Age
Age | <20 | 20-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75-84 | >85 |
Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
Race
- Vulvar cancer is more prevalent in the white race.[3]
Race | All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | Non-Hispanic | |
Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
References
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015